TG THERAPEUTICS INC shareholders Q3 2023

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
Parkman Healthcare Partners LLC 209,319$1,749,9070.32%
Blueshift Asset Management, LLC 61,075$510,5870.30%
AVAII WEALTH MANAGEMENT, LLC 34,022$284,4200.22%
Capital CS Group, LLC 17,525$146,5090.17%
Nebula Research & Development LLC 39,146$327,2610.17%
CLARK FINANCIAL SERVICES GROUP INC /BD 14,195$118,6700.16%
Jump Financial, LLC 472,972$3,954,0450.15%
AIGEN INVESTMENT MANAGEMENT, LP 94,748$792,0930.15%
Rhenman & Partners Asset Management AB 160,000$1,337,6000.14%
INNOVIS ASSET MANAGEMENT LLC 37,049$309,7300.12%
External links

This page lists TG THERAPEUTICS INC's shareholders in Q3 2023. To view TG THERAPEUTICS INC's shareholder history, click here.